Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Sodium valproate can worsen psoriasis-like skin conditions.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

The document concludes that various topical medications are effective for skin conditions but often cause skin irritation as a side effect.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Lactiplantibacillus plantarum lysate from green tea may help treat scalp seborrheic dermatitis.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Baricitinib works better than methotrexate for severe alopecia areata.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Selencin effectively reduces hair loss and improves hair health in diffuse alopecia.

Topical immunomodulators are effective and safe for treating immune-related skin conditions.

Aminopterin strongly suppresses epithelial tissues and can treat certain skin conditions but has significant side effects.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Finasteride can cause rare but serious skin rashes.

Trimethoprim-sulfamethoxazole can cause aseptic meningitis.

Switching from escitalopram to duloxetine improved hair loss.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Prednisolone improved symptoms in a woman with Cronkhite-Canada syndrome, but regular screenings are needed due to cancer risk.